These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2870608)

  • 1. [Chronic treatment of schizophrenia with injectable bromperidol decanoate].
    Suárez Richards M
    Acta Psiquiatr Psicol Am Lat; 1985 Sep; 31(3):222-8. PubMed ID: 2870608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bromperidol decanoate in the residual phase of schizophrenia].
    Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
    Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
    Woggon B
    Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].
    Levi Minzi A; Laviani M
    Minerva Psichiatr; 1992; 33(1):51-5. PubMed ID: 1406161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
    Pérez C; Stier Rosner SE
    Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The initial US clinical experience in the management of schizophrenic patients with bromperidol.
    Gardner E
    Acta Psychiatr Belg; 1978; 78(1):134-46. PubMed ID: 347876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
    Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
    Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S; Cookson JC; Silverstone T
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a clinical trial with bromperidol C-C 2489/21.
    Weiser G
    Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
    Malfroid M; Hens L; Roosen P; Dom R
    Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open study with bromperidol in hospitalized chronic schizophrenic patients.
    Hermans W
    Acta Psychiatr Belg; 1978; 78(1):89-95. PubMed ID: 347883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with bromperidol in chronic psychoses].
    Bellomo LE; Rosset N; Tellarini L; Forconesi N
    Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of female schizophrenic patients with bromperidol, a new neuroleptic drug of the butyrophenone group with medium duration of action.
    Fleischhauer J
    Acta Psychiatr Belg; 1978; 78(1):118-28. PubMed ID: 347874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
    Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.